Skip to main content
. 2024 Oct 7;6(4):1–10. doi: 10.46989/001c.124270

Figure 3B. Estimated 3-year CNS-relapse free survival is 99% and 100% in cohort 1 and cohorts with non-significant P value (P-0.595).

Figure 3B.